Literature DB >> 1695871

Kallikrein messenger RNA in rat arteries and veins.

G M Saed1, O A Carretero, R J MacDonald, A G Scicli.   

Abstract

Glandular kallikrein (EC 3.4.21.8) belongs to a subgroup of serine proteases coded by a multigene family. A kininogenase resembling glandular kallikrein has been identified in vascular tissue; however, it is not clear whether it is synthesized by vascular tissue or taken up from plasma. To determine the potential for kallikrein synthesis in vascular tissues, we tested whether messenger RNA (mRNA) for glandular kallikrein is present in rat arteries and veins. Poly(A+) RNA was isolated from pools of arteries or veins (n = 3, 30 rats each). Poly(A+) RNA from the kidney and liver was used as a positive and negative control, respectively. As a probe, we used rat pancreatic kallikrein 32P-labeled complementary DNA, which recognizes mRNA of the entire rat kallikrein family. Slot-blot analysis indicated that kallikrein mRNA was present in mRNA from the arteries, veins, and kidney but not from the liver. Poly(A+) RNA from arteries and veins contained approximately 1% as much kallikrein mRNA as that from the kidney. To confirm the slot-blot results and determine whether the mRNA for true glandular kallikrein was present in vascular tissue, we employed a polymerase chain reaction assay, first using primers specific for the entire kallikrein family (which amplify a 430-bp fragment) and then using primers specific for true glandular kallikrein mRNA (which amplify a 370-bp fragment). After the polymerase chain reaction assay, both arteries and veins showed fragments of these sizes when tested with rat kallikrein complementary DNA probe, thus confirming the presence of glandular kallikrein mRNA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695871     DOI: 10.1161/01.res.67.2.510

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

1.  Vascular remodeling and the kallikrein-kinin system.

Authors:  Oscar A Carretero
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator.

Authors:  J S Keum; M A Jaffa; L M Luttrell; A A Jaffa
Journal:  J Biol Regul Homeost Agents       Date:  2014 Oct-Dec       Impact factor: 1.711

Review 3.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

4.  Identification of tissue kallikrein messenger RNA in human neutrophils.

Authors:  H F Wu; R D Venezie; W M Cohen; J W Jenzano; G L Featherstone; R L Lundblad
Journal:  Agents Actions       Date:  1993-01

Review 5.  Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.

Authors:  K Morgan
Journal:  Br Heart J       Date:  1994-09

6.  The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats.

Authors:  H R Holte; A Bjørnstad-Ostensen; T Berg
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells.

Authors:  Jerry G Webb; Yan Tan; Miran A Jaffa; Ayad A Jaffa
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

8.  Cyclic AMP selectively enhances bradykinin receptor synthesis and expression in cultured arterial smooth muscle. Inhibition of angiotensin II and vasopressin response.

Authors:  B S Dixon
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Effects of Hoe 140, a bradykinin B2-receptor antagonist, on renal function in conscious normotensive rats.

Authors:  P Madeddu; V Anania; P P Parpaglia; M P Demontis; M V Varoni; G Pisanu; C Troffa; G Tonolo; N Glorioso
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

Review 10.  Development biology of the renal kallikrein-kinin system.

Authors:  S S el-Dahr
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.